Nandrolone can do this easily, as long as doctors have a very close monitoring on hematocrit since older men tend to have more problems with polycythemia https://www.nytimes.com/2010/08/31/health/research/31muscle.html?adxnnl=1&adxnnlx=1283259693-/5OVKCtiMHD2uTxULb30yQ
Doctors Seek Way to Treat Muscle Loss Read More »
https://www.businessweek.com/lifestyle/content/healthday/642400.html?chan=rss_topStories_ssi_5 A study published in the Public Library of Science (PLoS) in 2010 concluded that four anti-HIV drugs also inhibit XMRV replication.[33] The drugs were two retroviral integrase inhibitors; raltegravir (Merck & Co., brand name Isentress), L-000870812 (Merck & Co.), and two nucleoside reverse transcriptase inhibitors; tenofovir disoproxil fumarate (Gilead Sciences, brand name Viread), and zidovudine (GlaxoSmithKline, azidothymidine (AZT)). Synergistic effects were reported when
Can HIV medications treat Chronic Fatigue Syndrome? Read More »
Introducción Mi relación con la sustitución hormonal ha sido larga y fructífera. Yo fui diagnosticado con testosterona baja en 1993, a la edad de 34, luego de haber estado viviendo con VIH por 11 años. Yo había perdido 14 libras (6,35 Kg) involuntariamente, me sentía cansado y deprimido, y no tenía deseo sexual en lo
IAC Summary on New Drugs and New Combinations – How will They Change What We Do? Vienna July 18-23 2010 Joe Eron, Univ of North Carolina This year’s IAC was one of the most exciting and data-filled International AIDS meetings since Vancouver in 1996. The defining presentation of the meeting was the CAPRISA 004 study that
New Drugs and New Combinations – How will They Change What We Do? Read More »
This report reviews the status of research of drugs for HIV, TB, Hepatis C, immune based therapies. https://i-base.info/files/2010/06/2010-pipeline-webFINAL.pdf
HIV, TB, Hep C, Immune therapies 2010 Pipeline Report Read More »
What am I going to do now, Nelson? Aug 6, 2010 Hi Nelson, I hope all is well. Last year you told me about the trial with ibalizumab at ACRIA and I received the meds for about 1 year. In the beginning of thet trial the virus became undectadable but then it started to go
What am I going to do now, Nelson? Read More »
My Web page on amazon.com showing all my books in print and kindle versions. https://www.amazon.com/-/e/B003E3RYKY My book: Testosterone: A Man’s Guide is up as of today! I hope everyone enjoys it. Nelson
New Book Removes Barriers for Men Who Need Testosterone Therapy Read More »
I am excited to have been invited to speak at the International AIDS Conference in Vienna in two weeks This is my workshop https://pag.aids2010.org/session.aspx?s=419 https://pag.aids2010.org/PAGHome.aspx?pid=53000
International AIDS Conference- My workshop on Nutrition and Metabolic Disorders Read More »
Wellcare put together a great summary of all codes used for reimbursement. Medicare decided in January 2010 to cover HIV facial lipoatrophy products as long as the patient has depression induced by this condition. https://www.wellcare.com/WCAssets/corporate/assets/HS134_Dermal_Injections_for_Facial_Lipodystrophy_Syndrome.pdf
This company is seeking to get approval of a drug protocol that will speed up the normalization of the Hypothalamus-Pituitary-Gonadal (HPG) Axis after long term use of anabolic steroids or testosterone for medical or non medical uses. Cessation of anabolics or testosterone replacement causes androgen -induced hypogonadism that can negatively impact someone’s health if the
Pipeline Problems by David Evans In the past month, two companies shelved their once-promising experimental HIV drugs, citing the challenging nature of bringing a profitable product to market. Has the overwhelming success of modern-day HIV drugs jeopardized the future of new HIV treatment options? Since Matt Sharp first learned that he was HIV positive in
